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Aim. This paper describes the current infection control practices for CVC care and 
compares these to evidence-based practice guidelines. 
 
Background. Intensive care patients with central venous catheters (CVCs) are at risk 
of catheter-related infection, which increases morbidity, mortality and health care 
costs. Infection control practices, including care of intravenous administration sets 
and catheter sites, are undertaken by nurses in an attempt to avoid infection. Although 
practice guidelines are available, infection control practices may vary between 
practitioners and institutions; however, current practice has not been formally 
surveyed. 
 
Method. A prospective, cross-sectional descriptive survey was carried out. Intensive 
care units (n = 14) in Australia were surveyed about their infection control policies for 
CVC care. Results were tabulated and compared with evidence-based practice 
guidelines. 
 
Results. A wide variety of responses was received about duration of administration 
set use for standard, parenteral nutrition and propofol (lipid-based anaesthetic) 
infusions; ad hoc administration set connection technique; dressing frequency, 
materials and solutions; and barrier precautions used during procedures. There was 
inconsistent adherence to the guidelines. 
 
Conclusion. There is variation in the infection control approach to CVC care. Greater 
adherence to existing Centers for Disease Control Guidelines would assist in the 
standardization of best practice and facilitate evidence-based care. 
 
What is already known about this topic 
Patients with central venous catheters are at risk of catheter-related infection, which 
increases morbidity, mortality and health care costs. 
  
 Many nursing practices attempt to minimize infective risk, although not all are 
supported by evidence. 
  
 The Centers for Disease Control provide evidence-based practice guidelines for the 
prevention of infection and care of central venous catheters. 
 
 
What this paper adds 
The state of current nursing practice with regards to infection control with central 
venous catheters. 
  
 The level of adherence by nurses to the Centers for Disease Control practice 
guidelines. 
  
 Recommendations for nursing practice, education and future research. 
 
 
 Background 
Many patients, particularly those in intensive care units (ICUs), have a central venous 
catheter (CVC) for the administration of fluid, nutrition and medication, or for 
intravascular monitoring. CVCs break the body's natural defence barrier (the skin), 
and so put the patient at risk of catheter-related infection, of which an estimated 
200,000 cases occur worldwide each year (Mermel 2000). Catheter-related infection 
is devastating, with increased suffering and risk of death for patients, and increased 
institutional costs due to the increased length and complexity of hospital admission 
(Pittet et al. 1994). 
 
The CVCs are requested and inserted by physicians; however post-insertion catheter 
care is predominantly a nursing responsibility, providing an opportunity for nursing 
care to influence infection rates. Many practices are used to minimize infection risk, 
including procedures involving the intravenous administration sets and catheter entry 
sites. Varying levels of evidence exist for the efficacy of infection control procedures 
involving CVC care; however this is improving as more research is undertaken and 
published. 
 
The Centers for Disease Control (CDC) (Atlanta, GA, USA) is an important infection 
control body that has been influential in reviewing the evidence for effective infection 
prevention measures in many areas, including intravascular therapy. The CDC 
published guidelines for the prevention of intravascular catheter-related infection in 
1981 (CDC 1981), 1996 (Pearson 1996), and most recently in 2002 (O'Grady et al. 
2002). The Guidelines were developed by a multidisciplinary group of health care 
professionals, are evidence-based, and provide recommendations for best practice. 
Their goal is to promote patient safety and to decrease preventable infections 
(O'Grady et al. 2003). A wide variety of related topics is covered, including 
administration sets, injection ports, site care, and dressing regimes. In addition to 
general guidelines, specific guidelines are provided for various catheters, including 
CVCs. 
 
Although the CDC Guidelines have existed for the past two decades, little is known 
about what practitioners actually do in clinical practice, and how closely practice 
reflects the Guidelines. There is only one previous investigation into this area, and 
this was a practice survey conducted in 1992 (Clemence et al. 1995) using a 
questionnaire with nurses involved with CVCs in hospital or home settings in the 
USA. The investigated topics relevant to nurses included catheter site care (dressing 
type, frequency, antiseptic solutions, technique and protective garments). A range of 
practices was reported, and these were not always consistent with the evidence-based 
guidelines current at that time. These data support anecdotal reports of wide 
procedural variation in CVC infection control practice. However, as this was a single 
study, undertaken in one country, and is now a decade old, we considered that an 
investigation of current practice was required. 
 
The study 
Aim 
 
The aim of the study was to describe current infection control practices regarding 
CVC care in Australian ICUs and to compare practice with evidence-based practice 
guidelines. 
  
  
Design 
A prospective, cross-sectional, descriptive survey was carried out. 
  
  
Sample 
The sample was Australian ICUs (n = 14), with representation from each State and 
Territory. 
  
  
Questionnaire 
A questionnaire was developed using the CDC Guidelines for the Prevention of 
Intravascular Catheter-Related Infections (Pearson 1996, O'Grady et al. 2002). The 
relevant sections used were: Hand hygiene; Aseptic technique during catheter 
insertion and care; Catheter site care; Catheter-site dressing regimes; Replacement of 
administration sets; and IV-injection ports (see Table 1). The questionnaire was 
validated by a reference group composed of expert ICU nurses, who considered the 
research questions and the CDC Guidelines, pilot-tested the questionnaire, and 
determined that it accurately reflected the phenomena of interest. Demographic data 
were obtained to describe the ICU, patient population and the types of catheters used. 
  
Infection control procedure Current 
practice 
CDC Guidelines (O'Grady et al. 2002) Level of 
evidence* 
Duration of administration set 
use for standard infusions 
  IX.A.1. 'Replace administration sets, 
including secondary sets and add-on 
devices, no more frequently than at 72-
hour intervals ' (O'Grady et al. 2002, 
p. 15) 
IA 
Duration of administration set 
use for total parenteral nutrition 
infusions 
  IX.A.2. 'If the solution contains only 
dextrose and amino acids, the 
administration set does not need to be 
replaced more frequently than every 
72 hours'(O'Grady et al. 2002, p. 15) 
II 
Duration of administration set 
use for lipid emulsion infusions 
  IX.A.2. 'Replace tubing used to 
administer blood, blood products, or lipid 
emulsions (those combined with amino 
IB 
Infection control procedure Current 
practice 
CDC Guidelines (O'Grady et al. 2002) Level of 
evidence* 
acids and glucose in a 3-in-1 admixture 
or infused separately) within 24 hours of 
initiating the infusion'  (O'Grady et al. 
2002, p. 15) 
Duration of administration set 
use for propofol infusions 
  'IX.A.3. 'Replace tubing used to 
administer propofol infusions every
12 hours, as per the manufacturer's 
recommendation (for infusions)' 
(O'Grady et al. 2002, p. 15) 
IA 
  X.A. Clean injection ports with 70% 
alcohol or an iodophor before accessing 
the system' (O'Grady et al. 2002, p. 15) 
IA Decontamination of CVC hub-
administration set connection 
prior to every 
connection/disconnection of an 
administration set   III.A. 'Observe proper hand-hygiene 
procedures either by washing hands 
with conventional antiseptic-containing 
soap and water or with waterless 
alcohol-based gels or foams. Observe 
hand hygiene before and after
accessing   (or) repairing an 
intravascular catheter' (O'Grady et al. 
2002, p. 13) 
IA 
  VII.A. 'Use either sterile gauze or sterile, 
transparent, semi-permeable dressing to 
cover the catheter site'  (O'Grady et al. 
2002, p. 14) 
IA 
  VII.C. 'If the patient is diaphoretic, or if 
the site is bleeding or oozing, a gauze 
dressing is preferable to a transparent, 
semi-permeable dressing' (O'Grady 
et al. 2002, p. 14) 
II 
  VI.D. 'No recommendation can be made 
for the use of chlorhexidine sponge 
dressings to reduce the incidence of 
infection' (O'Grady et al. 2002, p. 18) 
Unresolved 
issue 
CVC dressing type 
  VI.E. Do not use chlorhexidine sponge 
dressings in neonates aged <7 days or 
of gestational age <26 weeks'  (O'Grady 
et al. 2002, p. 18) 
II 
  VI.C.1 'Replace catheter-site dressing 
when it becomes damp, loosened, or 
soiled or when inspection of the site is 
necessary' (O'Grady et al. 2002, p. 17) 
IA Maximum time that CVC 
dressings are left intact 
  VI.C.2 'Replace dressings used on 
short-term CVC sites every 2 days for 
gauze dressings and at least every 
7 days for transparent dressings, except 
in those paediatric patients in which the 
risk of dislodging the catheter outweighs 
the benefit of changing the dressing' 
(O'Grady et al. 2002, p. 17) 
IB 
Solution used for CVC site care   VI.A.1. Disinfect clean skin with an 
appropriate antiseptic during dressing 
changes. Although a 2%  chlorhexidine-
based preparation is preferred, tincture 
of iodine, an iodophor, or 70% alcohol 
can be used'  (O'Grady et al. 2002, p. 
14) 
IA 
Infection control procedure Current 
practice 
CDC Guidelines (O'Grady et al. 2002) Level of 
evidence* 
  VI.A.2. No recommendation can be 
made for the use of chlorhexidine in 
infants aged <2 months (O'Grady et al. 
2002, p. 14) 
Unresolved 
issue 
  IV.C. 'Wear clean or sterile gloves when 
changing the dressing on intravascular 
catheters' (O'Grady et al. 2002, p. 14) 
IC Barrier precautions are used for 
CVC care 
  III.B. 'Use of gloves does not obviate the 
need for hand hygiene' (O'Grady et al. 
2002, p. 13) 
IA 
*Level of Evidence: IA, strongly recommended for implementation and strongly supported by well-
designed experimental, clinical, or epidemiologic studies; IB, strongly recommended for 
implementation and supported by some experimental, clinical, or epidemiologic studies, and a 
strong theoretical rationale; IC, required by (U.S.) state or federal regulations, rules or standards; 
II, suggested for implementation and supported by suggestive clinical or epidemiologic studies or a 
theoretical rationale; Unresolved issue, represents an unresolved issue for which evidence is 
insufficient or no consensus regarding efficacy exists. 
CDC, Centers for Disease Control; CVC, central venous catheter. 
Table 1 Questionnaire for comparison of current practice with CDC Guidelines 
 
 
Data collection 
The ICUs were contacted by telephone and invited to participate following an 
explanation of the survey purpose. The questionnaire was then administered by 
telephone interview with the charge nurse or senior nurse on duty. Respondents were 
asked to give answers that reflected unit policy or the predominant unit practice if no 
formal policy existed. Participants' answers were responded to during the interview in 
an impartial manner, with no discussion or inference as to the correctness of 
responses. 
  
  
Ethical considerations 
Institutional Ethics Committee approval was not required, as the practice survey had 
no impact on patient care or confidentiality. An explanation of the survey was 
provided over the telephone and completion of the questionnaire was assumed to 
imply consent. Confidentiality of individual and institutional responses was protected. 
  
  
Data analysis 
Continuous variables were calculated for range, mean and standard deviation values. 
Categorical data was described using percentages and frequencies. Some responses 
were given in hours, days or frequencies per week. To allow comparison of these 
data, they were transformed into hourly data, for example procedures performed twice 
weekly (alternating every third then fourth day) were classified as a maximum of 96 
hours. All analysis was undertaken used the Statistical Package for the Social 
Sciences version 10·0 (SPSS®, Chicago, IL, USA). A comparison was made of all 
responses with the relevant CDC Guidelines for the Prevention of Intravascular 
Catheter-Related Infections. These were last updated in 2002 (O'Grady et al. 2002), 
although the 1996 version (Pearson 1996) was in place for the period of this survey. 
The minor relevant variations between the two versions of the Guidelines were 
accounted for during data analysis. 
 
 
 Results 
Sample 
 
All of the 14 ICUs agreed to complete the questionnaire, and all were in public 
(government-operated) teaching hospitals in metropolitan or major regional areas (see 
Table 2). A combination of plain and antimicrobial catheters was used routinely in all 
units. 
  
Size of ICU Patients admitted per year 
Beds Sample Patients Sample 
6 3 500 4 
7 14 6 501 1199 3 
15 24 5 1200 1500 7 
ICU, intensive care unit. 
Table 2 Characteristics of participating ICUs 
 
 
Duration of intravenous administration set use 
 Standard infusions (crystalloid or crystalloid-based) 
A wide range of responses (72168 hours) was given, with a mean of 114·9 hours (sd 
43·3), which equates to just under 4 days of use. The most frequent responses were at 
the two extremes, with 5 units each reporting use of 72 and 168 hours (see Table 3). 
The CDC Guidelines recommend that administration sets for these infusions are 
replaced no more frequently than every 72 hours. 
  
Infusion type Set usage* (hours) No. of ICUs % 
72 14 100 Standard 
<72 0 0 
72 10 71 TPN 
<72 4 29 
24 10 71 Lipid 
>24 4 29 
12 2 14 Propofol 
>12 12 86 
*Data in bold italics represent the recommended duration of administration set use as per the CDC 
Guidelines for the Prevention of Intravascular Catheter-Related Infections.  
CDC, Centers for Disease Control; TPN, total parenteral nutrition. 
Table 3 Reported maximum duration of intravenous administration set use compared 
with the CDC Guidelines 
  
Total parenteral nutrition 
The response range was also wide, from 24 to 168 hours, with a mean reported 
maximum usage of 87·4 hours (sd 53·8), which equates to 3·6 days of use. The most 
commonly occurring response was 24 hours (see Table 3). The ICUs which infused a 
non-lipid total parenteral nutrition (TPN) solution (amino acids and dextrose) and a 
separate lipid emulsion reported identical usage timeframes for the administration 
sets. The CDC Guidelines recommend replacement of administration sets used for 
non-lipid TPN no more frequently than every 72 hours, but a shorter 24-hour usage 
for lipid-containing TPN and for separate lipid emulsions. 
  
  
Propofol 
The ICUs most frequently reported a 72-hour maximum usage for propofol 
administration sets, but again, the range of responses was wide, from 12 to 168 hours 
(mean 96·0, sd 50·5) (see Table 3). The CDC Guidelines recommend 24-hour 
administration set use for lipid emulsions such as propofol. 
  
  
Ad hoc administration set change procedure 
The majority of units (64%) reported that they swabbed the catheter-set connection 
when reconfiguring an administration set at a time other than initial catheter insertion 
or routine set change. The predominant technique involved a 70% alcohol 
prepackaged swab, but others reported using chlorhexidine or alcoholic chlorhexidine. 
The 1996 Guidelines recommended that the catheter hub be decontaminated before 
accessing the administration set, although a specific antiseptic was not stated. This 
procedure is no longer covered in the 2002 version of the Guidelines; however, it is 
reasonable to generalize the recommendations for accessing injection ports to the 
accessing of the administration set, as both involve breaking the sterile circuit and 
potentially allow microbial contamination. The Guidelines recommend that injection 
ports be cleaned immediately prior to use with 70% alcohol or an iodophor (e.g. 
Betadine®; Purdue-Pharma L.P., Stanford, CT, USA). 
  
  
Dressing material 
Semi-permeable transparent dressings were predominantly in use, with gauze 
dressings reported by only one unit (see Table 4). The Guidelines equally recommend 
both of these dressings except in cases of severe diaphoresis or a bleeding or oozing 
catheter site, in which case gauze dressings are preferred. 
  
  No. of ICUs % 
Type 
  Transparent semi-permeable 13 93 
  Gauze 1  7 
Frequency 
  Transparent semi-permeable 
    Weekly 11 85 
    >Weekly 2 15 
  Gauze 
  No. of ICUs % 
    48 hours 0  0 
    >48 hours 1 100 
Solution 
  2% Chlorhexidine 0  0 
  Tincture of iodine/iodophor 3 21·5 
  70% Alcohol 3 21·5 
  70% Alcohol/0·5% chlorhexidine 3 21·5 
  Saline 3 21·5 
  Chlorhexidine sponges 2 14 
*Data in bold italics represent the recommended CVC site care as per the CDC Guidelines for the 
Prevention of Intravascular Catheter-Related Infections. 
CVC, central venous catheter; CDC, Centers for Disease Control; ICU, intensive care unit. 
Table 4 Reported frequency and type of CVC site care compared with the CDC 
Guidelines 
 
 
Dressing frequency 
A wide range of answers from 72 to 240 hours was reported for frequency of semi-
permeable transparent dressing replacement, with a mode of 168 hours and mean of 
142·2 hours (sd 59·2). The one unit using gauze dressings replaced these at a 
maximum of 96 hourly intervals (see Table 4). The 1996 version of the CDC 
Guidelines considered dressing frequency to be an unresolved issue and gave no 
recommendations. The revised 2002 CDC Guidelines advocate replacement of gauze 
dressings every other day and at least weekly replacement of semi-permeable 
transparent dressings. Many units commented that in addition to the routine 
timeframes, dressing changes were performed as necessary. Reasons for this were not 
requested. The Guidelines advise that dressings also be replaced if they are damp, 
loose or soiled, or for site inspection. 
  
  
Dressing solutions 
Most units reported use of antimicrobial products for postinsertion catheter site care. 
Reponses were almost evenly divided between five products (see Table 4). The 1996 
CDC Guidelines did not include any recommendation for antimicrobial solution use 
during CVC dressing. The revised 2002 Guidelines recommend that skin be 
disinfected during dressing changes with a 2% chlorhexidine-based preparation (for 
patients over 2 months of age); however, tincture of iodine, an iodophor (e.g. 
Betadine®), or 70% alcohol are also acceptable. Use of a chlorhexidine impregnated 
sponge (BiopatchTM) is considered an unresolved issue by the CDC and no 
recommendations are made for its use. 
  
  
Barrier precautions 
Protective garments were worn in 57% of units to perform a dressing or routine 
administration set change. Plastic non-sterile aprons were most commonly used, 
followed by non-sterile and then sterile cloth gowns. All units reported wearing 
gloves (sterile 57%, non-sterile 43%) to perform a CVC dressing or routine 
administration set change. Most did not use masks, although 14% reported wearing a 
mask for processes involving TPN. 
 
The CDC Guidelines do not advise the use of protective garments for CVC care and 
state that masks are only to be used when admixing TPN, a procedure that is now 
generally performed in a pharmacy rather than an ICU. The Guidelines recommend 
that gloves should be worn for a dressing change, but whether these should be sterile 
or non-sterile is an unresolved issue. It is further noted that proper hand hygiene (with 
antiseptic containing soap and water or waterless alcohol-based gels or foams) must 
be attended to before and after the procedure, in addition to the use of gloves. The 
Guideline recommendations for accessing administration sets include no reference to 
gloves, but do state the necessity for proper hand hygiene as above. 
 
 
 Discussion 
The survey found only two areas of infection control practice that were totally 
adherent to the CDC Guidelines: duration of administration set use for standard 
infusions and type of catheter dressing. The 100% Guideline adherence for use of 
general infusion administration sets is probably explained by the non-specific nature 
of the recommendation; that is, sets are recommended to be replaced no more 
frequently than at 72 hours, rather than giving a definite optimal duration of usage. 
The broad nature of this recommendation meant that, although there was a large 
variation in the reported timeframes used (72168 hours), they were all Guideline 
compliant. 
 
The results displayed two strong trends. First, one-third of ICUs reported replacing 
administration sets 72 hourly, which suggests that the Guidelines may be 
misinterpreted as recommending a maximum rather than a minimum 72 hours of use. 
Conversely, another third of ICUs used administration sets for 168 hours (1 week). 
This timeframe is within the broad Guidelines, but is far removed from the well-
researched 72-hour interval, although reports are beginning to appear in the literature 
supporting longer administration set use (Raad et al. 2001, Rickard et al. 2002). There 
has been no published evaluation of the inherent efficacy of routinely replacing sets, 
although occasionally it is noted the practice may have no effect at any time interval 
(Maki et al. 1987, Ducharme et al. 1988). Routinely changing administration sets 
before 1 week, or indeed at any time, may be a waste of time and resources. However, 
until a randomized controlled trial supports use to beyond 1 week, it would be prudent 
to limit administration-set use to this, rather than an unlimited time. 
 
Semi-permeable transparent dressings seem to be predominantly used in Australian 
ICUs, with all respondents reporting this dressing type, with the exception of one unit 
using gauze. The CDC equally recommends these two dressing types. This is 
consistent with a recent systematic review which found no difference between the 
products and attributed this to the small sample sizes studied to date (Gillies et al. 
2003). In cases of diaphoresis or a bleeding or oozing catheter site, gauze dressings 
are recommended by the CDC. Our survey did not seek to address these special 
circumstances and we cannot say whether Australian ICU nurses substitute gauze 
dressings in these cases. 
 
The study identified several infection control practices that were not in accordance 
with the CDC Guidelines and thus are areas for potential practice improvement. These 
were: duration of administration set use for TPN and lipid emulsions, including 
propofol; the procedure for ad hoc administration set changes; frequency of dressing 
replacement; antimicrobial solution used when dressing the catheter site; and barrier 
precautions used for catheter care. 
 
Many ICUs are currently replacing non-lipid TPN administration sets more 
frequently, and lipid sets (including propofol) less frequently than the Guidelines 
recommend. Historically, all TPN sets were thought to carry a significantly higher 
microbial growth risk, but more recent data suggest that it is the lipid emulsion which 
is responsible (Didier et al. 1998, Matlow et al. 1999). Our respondents did not 
differentiate between lipid emulsion-only solutions and other forms of TPN and rarely 
recognized that propofol, a frequently used ICU infusion, is a lipid emulsion. This is a 
potential avenue for further education and practice change. 
 
Many units reported complex infection control precautions for replacement of 
administration sets at routine intervals. In contrast, there was a lack of rigour in the 
approach used to decontaminate connections when replacing sets intermittently. 
Administration set configurations are not static throughout the catheterization period, 
but are manipulated frequently to add, remove or reconfigure infusions. A thorough 
reading of the entire CDC Guidelines supports the fact that hand hygiene and set 
decontamination should be attended in this situation. However, there is no specific 
recommendation covering the procedure, and this may at least partially explain the 
high level of practice uncertainty. It may be beneficial for future versions of the 
Guidelines to specifically outline the recommended procedure for intermittently 
connecting/disconnecting administration sets. 
 
The reported frequencies for dressing replacements were not all consistent with the 
current CDC Guidelines and a wide range of timeframes was quoted. This is perhaps 
due to the 1996 Guidelines (in place during the study) giving no recommendation for 
CVC dressing frequency. In order to comply with the 2002 Guidelines, some units 
will need to change dressings more frequently. Many respondents commented that 
additional dressings were performed as necessary. This is consistent with the 
Guidelines, which recommend replacement if the dressing is damp, loosened or 
visibly soiled. Whilst frequency of gauze dressings is definitively addressed, the 
Guidelines for replacing semi-permeable transparent dressings are broad, giving a 
minimum (weekly) rather than a finite timeframe. This is no doubt because of the 
limited amount of quality published research on the topic, with only one study 
(Rasero et al. 2000) cited by the Guidelines. 
 
The 1996 Guidelines also made no mention of the practice of decontaminating the 
catheter site during dressing replacements. Despite this, all units reported the practice 
as standard. The updated Guidelines now recommend that skin be disinfected during 
dressing changes with one of three solutions. Current practice, which involves a large 
variety of antimicrobial products, as well as saline, will need to be adapted 
accordingly. Although the Guidelines allow other solutions, 2% chlorhexidine is 
recommended. This is supported by a recent meta-analysis of 4143 catheters, which 
showed a halving of infection risk when chlorhexidine rather than 10% 
povidineiodine was used for insertional and ongoing catheter site care 
(Chaiyakunapruk et al. 2002). The analysis included chlorhexidine at concentrations 
of 0·51·0% in alcohol and 0·52·0% in aqueous, which suggests that levels lower than 
the CDC recommended 2% are acceptable. The most recently available site-care 
product, chlorhexidine-impregnated sponges (BiopatchTM), are being used in some 
centres in Australia, despite their increased cost. However, the Guidelines state that 
there is inadequate research evidence at this time to recommend their use. 
 
The CDC Guidelines do not advocate protective garments for CVC dressings or 
administration set changes, yet a number of units used these routinely. Under standard 
precautions, unless soiling with blood or body fluids is anticipated, gowning of any 
type is unnecessary, costly and should be abandoned. All ICUs reported use of sterile 
or non-sterile gloves to perform dressings. Both glove types are acceptable for 
dressing replacement under the Guidelines, but are recommended purely as standard 
precautions, that is, to protect staff from possible body fluid exposure rather than to 
prevent catheter infection. Units currently using the more expensive sterile gloves 
should consider changing to the clean, non-sterile variety. All units also reported 
wearing gloves routinely to replace administration sets. This is not a situation where 
exposure with blood or body fluids should be anticipated (unless dis/connecting a 
blood-product infusion), is not recommended by the Guidelines, and should be 
discontinued. A small number of units reported the use of masks whilst manipulating 
TPN administration sets. The CDC Guidelines do not recommend masks for this 
procedure and units should avoid this unnecessary practice. The Guidelines do 
recommend stringent attention to hand hygiene and aseptic technique for all aspects of 
CVC care. 
 
The predominant findings of this study were the wide diversity of current practice 
involving infection control care of CVCs, and lack of consistent adherence to the 
CDC Guidelines. These findings are consistent with a survey on CVC care undertaken 
in the USA in 1992, which also found varied practice and divergence from CDC 
Guidelines (Clemence et al. 1995). Sub-optimal compliance with practice guidelines 
has also been observed in other infection control studies in the areas of hand hygiene, 
glove use, needle recapping, and respiratory isolation (White et al. 1997, Tait et al. 
2000, Harbath et al. 2002, Stein et al. 2003). 
 
 Limitations 
There are some limitations to the study. The sample size was small and limited to one 
country, and therefore cannot be interpreted as representative of all ICU practice. 
However, it did include participants from each Australian State and Territory and the 
results give some indication of Australian practice. The decision to administer the 
questionnaire to the senior nurse on duty, and request information on unit policy or 
predominant unit practice, assumed that the nurse would know this information and 
would give an accurate answer. It is possible however, that responses actually 
reflected the individual's practice bias or a perception of the 'right' answer. The one 
previous practice survey on this topic also involved a senior nursing sample, and a 
practice questionnaire was distributed to attendees at a professional conference 
(Clemence et al. 1995). Results from self-report questionnaire surveys such as ours 
are subject to limitations, in that self-reported infection control adherence may be 
overestimated compared with that measured by independent observers (Henry et al. 
1994). An observational design would have provided a more direct measure of 
infection control practice, although such studies require increased resources and, if 
participants know that they are being observed, the Hawthorne effect may lead to 
behaviour being modified (Henry et al. 1994, Harbath et al. 2002). We did not have 
the resources to undertake a multi-centre observational study and instead used the 
questionnaire method, as have previous studies seeking to describe elements of 
infection control practice (Alvaran et al. 1994, Clemence et al. 1995, Beaujean et al. 
2000, Tait et al. 2000). 
 
Conclusions 
Although the study revealed a significant level of discrepancy between the CDC 
Guidelines and current practice, they do not explain why such discrepancies exist. The 
Guidelines are the most useful evidence-based document currently available for 
intravascular catheter care and are widely published and cited, and it is reasonable to 
expect that they should be reflected in clinical practice. Why is this not happening? 
Whilst we do not assume that all individual nurses would be familiar with the CDC 
Guidelines, those responsible for the development or updating of unit policies should 
be. Additionally, it is important periodically to search the literature for relevant 
studies published after the Guidelines' publication and adapt policy and practice 
accordingly. Our finding that there is lack of adherence to evidence in unit policies 
almost certainly reflects a lack of resources or appropriate staffing to allow policies to 
be developed that reflect the current literature. Clinical policy development in 
Australia is often undertaken by nurses with advanced clinical skills but limited 
experience in information retrieval and analysis. It would be beneficial for institutions 
to provide further support and education in policy development, and to encourage 
clinical nurses to develop policies in consultation with local nurse researchers, 
academics and other appropriate staff, such as librarians. 
 
The use of CVCs in large numbers and for extended periods of time is a relatively 
new phenomenon, and some aspects of CVC care have not yet been fully investigated. 
The CDC Guidelines are based on the best available evidence, but in some cases 
recommendations cannot be given because of inadequate or conflicting research. This 
may limit the perceived usefulness of the Guidelines by clinicians. Nurses have been 
introduced to an evidence-based culture relatively recently, and the knowledge-
practice gap is a well-known problem (Retsas & Nolan 1999, Pearson 2002). In recent 
years, antimicrobial catheters have been extremely effective in lowering catheter 
infection rates (Veenstra et al. 1999) and are used widely, although the CDC 
recommends their use only if infection rates remain a concern after all other basic 
precautions have been taken. In our study, almost all units reported using 
antimicrobial catheters as standard. Perhaps the use of these catheters has led to a 
complacent attitude to traditional anti-infective precautions, such as those covered in 
this study. Staff education about antimicrobial catheters should emphasize their role 
as an adjunct to, not a replacement for, basic principles of infection control. 
 
For the purposes of the study, we assumed that clinical practice guidelines are 
beneficial to patients and that they should be reflected in good practice. It could 
perhaps be argued that reliance on guidelines detracts from individual professional 
accountability. Ideally, all nurses would frequently review the research literature and 
incorporate relevant findings into practice; however, realistically, busy clinicians may 
not have the time, skills or inclination to do so. Clinical practice guidelines aim to 
facilitate evidence-based practice, decrease practice variation, and promote cost-
effective care (O'Grady 2003). Guidelines developed by reputable organisations such 
as the CDC are a useful tool for navigating the published evidence, which continues 
to grow in both quantity and complexity. The CDC Guidelines provide guidance on 
care interventions that are effective both individually and in total. Recent data from 
2043 ICU patients showed a 57% reduction in catheter-associated bloodstream 
infection in the 13 months after the provision of a comprehensive educational 
intervention based on the CDC Guidelines (Warren et al. 2003). We contend that by 
providing Guideline-compliant care, nurses can demonstrate that they are delivering 
high quality nursing care for patients with CVCs. 
 
 Recommendations 
On the basis of the study, we recommend that: 
 
1.  Individual units review their policies and procedures for care of CVCs, with 
particular reference to the CDC Guidelines. Our questionnaire may be a useful quality 
audit tool for practice review. 
  
2.  Where diversity of practice is found, education and motivation for staff should be 
given about the 2002 CDC Guidelines and these should be formalized in the relevant 
institutional policies. 
  
3.  Further research is undertaken to resolve contentious or unsupported aspects of 
CVC care, and to evaluate effective ways to ensure that clinicians are aware of, and 
comply with, evidence-based practice guidelines. The research should be of rigorous 
scientific design and execution, including large multi-site, randomized controlled 
trials where appropriate. Specific areas requiring further investigation include: 
  
 the optimal maximum duration of administration set use. 
  
 the decontamination technique to be used when connecting administration sets on a 
routine or ad hoc basis. 
  
 the optimal frequency for CVC dressing replacement. 
  
 the efficacy of barrier precautions when manipulating administration sets or site 
dressings. 
  
 the efficacy of chlorhexidine-impregnated sponges for CVC site care. 
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